XML 72 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Payments (Tables)
 6 Months Ended
Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based compensation expense included in condensed consolidated statements of income
The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions)
2017
 
2016
 
2017
 
2016
Research and development
$
17.5

 
$
21.5

 
$
36.2

 
$
42.9

Selling, general and administrative
18.9

 
28.7

 
48.3

 
63.4

Restructuring charges
—

 
—

 
—

 
(1.8
)
Subtotal
36.4

 
50.2

 
84.5

 
104.5

Capitalized share-based compensation costs
(2.4
)
 
(4.4
)
 
(5.1
)
 
(7.5
)
Share-based compensation expense included in total cost and expenses
34.0

 
45.8

 
79.4

 
97.0

Income tax effect
(8.5
)
 
(12.7
)
 
(20.9
)
 
(27.9
)
Share-based compensation expense included in net income attributable to Biogen Inc.
$
25.5

 
$
33.1

 
$
58.5

 
$
69.1
Summary of share-based compensation expense associated with each of our share-based compensating programs
The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions)
2017
 
2016
 
2017
 
2016
Market stock units
$
3.0

 
$
7.9

 
$
12.6

 
$
21.3

Time-vested restricted stock units
27.6

 
33.9

 
54.5

 
64.0

Cash settled performance units
2.5

 
4.6

 
6.0

 
4.8

Performance units
1.2

 
1.3

 
5.7

 
8.2

Employee stock purchase plan
2.1

 
2.5

 
5.7

 
6.2

Subtotal
36.4

 
50.2

 
84.5

 
104.5

Capitalized share-based compensation costs
(2.4
)
 
(4.4
)
 
(5.1
)
 
(7.5
)
Share-based compensation expense included in total cost and expenses
$
34.0

 
$
45.8

 
$
79.4

 
$
97.0